Physique But Not Career Enhancing

The Nevada Supreme Court imposed a four-year suspension of an attorney retroactive to April 25, 2014 

Manansingh has admitted to the facts and violations alleged in the complaint. The record therefore establishes that Manansingh operated two companies with the purpose of selling physique-enhancing, non-FDA approved drugs that were labeled “For Research Use Only” in an effort to evade FDA scrutiny. He was convicted of introducing misbranded drugs into interstate commerce with intent to defraud or mislead, in violation of 21 U.S.C. §§ 331(a), 333(0(2), a felony. He was sentenced to four months of home detention with location monitoring and three years probation and was ordered to pay a $250,000 fine in $1,000 monthly payments. Thus, the record establishes that he violated RPC 8.4(b) and (c).

The case is In the Matter of Discipline of Chandan Manansingh. (Mike Frisch)